A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema

PHASE3CompletedINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

January 8, 2016

Primary Completion Date

November 1, 2019

Study Completion Date

November 1, 2019

Conditions
Macular Edema
Interventions
DRUG

Dexamethasone

Dexamethasone 700 μg intravitreal injection in the study eye on Day 1, Months 5, and 10.

PROCEDURE

Laser Photocoagulation

Laser photocoagulation on Day 1, and on Months 3, 6, and 9, if retreatment indicated.

Trial Locations (18)

1200

Asian Eye Institute, Makati City

1209

Peregrine Eye and Laser Institute, Makati City

100034

Peking University First Hospital, Beijing

100044

People's Hospital of Peking University, Beijing

100050

Beijing Friendship Hospital of Capital Medical University, Beijing

100730

Beijing Hospital, Beijing

Beijing TongRen Hospital, Beijing

Peking Union Medical College Hospital, Beijing

130041

The 2nd hospital of JiLin University, Changchun

200031

The Eye and ENT Hospital, Affiliated of Fudan University, Shanghai

210029

The First Hospital of Nanjing Medical University, Nanjing

300020

Tianjin Eye Hospital, Tianjin

300384

TianJin Medical University Eye Hospital, Tianjin

325027

Wenzhou Ophthalmic Centre, Wenzhou

410011

The Second Xiangya Hospital of Central South University, Changsha

430060

Renmin Hospital of Wuhan University, Wuhan

510060

Zhongshan Ophthalmic Center, Sun Yet-Sen University, Guangzhou

610041

West China Hospital, Sichuan University, Chengdu

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Tigermed Consulting Co., Ltd

INDUSTRY

lead

Allergan

INDUSTRY